ROIV - CIK 0001635088
Roivant Sciences Ltd. (ROIV) reported net income of -$299.77M for fiscal year 2026, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2026 | -$299.77M | -74.3% |
| FY 2025 | -$171.98M | -104.0% |
| FY 2024 | $4.35B | +531.0% |
| FY 2023 | -$1.01B | -19.4% |
| FY 2022 | -$845.26M | -4.5% |
| FY 2021 | -$809.23M | - |
Roivant Sciences Ltd. (ROIV) reported net income of -$299.77M for fiscal year 2026, as filed in its audited annual report with the SEC.
Between fiscal 2021 and fiscal 2026, Roivant Sciences Ltd.'s net income grew from -$809.23M to -$299.77M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.